Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

261 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial.
Claessen BE, Dangas GD, Weisz G, Witzenbichler B, Guagliumi G, Möckel M, Brener SJ, Xu K, Henriques JP, Mehran R, Stone GW. Claessen BE, et al. Among authors: mockel m. Eur Heart J. 2012 Mar;33(6):768-75. doi: 10.1093/eurheartj/ehr471. Epub 2012 Jan 12. Eur Heart J. 2012. PMID: 22240495 Clinical Trial.
Prognostic utility of left ventricular end-diastolic pressure in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Planer D, Mehran R, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Reyes SL, Stone GW. Planer D, et al. Among authors: mockel m. Am J Cardiol. 2011 Oct 15;108(8):1068-74. doi: 10.1016/j.amjcard.2011.06.007. Epub 2011 Jul 27. Am J Cardiol. 2011. PMID: 21798494 Clinical Trial.
Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysis.
Dangas GD, Mehran R, Nikolsky E, Claessen BE, Lansky AJ, Brodie BR, Witzenbichler B, Guagliumi G, Peruga JZ, Dudek D, Möckel M, Caixeta A, Parise H, White H, Stone GW; HORIZONS-AMI Trial Investigators. Dangas GD, et al. Among authors: mockel m. J Am Coll Cardiol. 2011 Jun 7;57(23):2309-16. doi: 10.1016/j.jacc.2011.01.038. J Am Coll Cardiol. 2011. PMID: 21636031 Clinical Trial.
Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
Stone GW, Parise H, Witzenbichler B, Kirtane A, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Lansky AJ, Mehran R. Stone GW, et al. Among authors: mockel m. J Am Coll Cardiol. 2010 Nov 2;56(19):1597-604. doi: 10.1016/j.jacc.2010.08.608. Epub 2010 Oct 1. J Am Coll Cardiol. 2010. PMID: 20888162 Clinical Trial.
Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial).
Tsujita K, Nikolsky E, Lansky AJ, Dangas G, Fahy M, Brodie BR, Dudek D, Möckel M, Ochala A, Mehran R, Stone GW. Tsujita K, et al. Among authors: mockel m. Am J Cardiol. 2010 May 15;105(10):1385-94. doi: 10.1016/j.amjcard.2010.01.001. Epub 2010 Apr 2. Am J Cardiol. 2010. PMID: 20451683 Clinical Trial.
Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial.
Généreux P, Mehran R, Palmerini T, Caixeta A, Kirtane AJ, Lansky AJ, Brodie BR, Witzenbichler B, Mockel M, Guagliumi G, Peruga JZ, Dudek D, Fahy MP, Dangas G, Stone GW; HORIZONS-AMI Trial Investigators. Généreux P, et al. Among authors: mockel m. EuroIntervention. 2011 Dec;7(8):905-16. doi: 10.4244/EIJV7I8A144. EuroIntervention. 2011. PMID: 22157475 Clinical Trial.
Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial.
Stone SG, Serrao GW, Mehran R, Tomey MI, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Brener SJ, Dangas G, Stone GW. Stone SG, et al. Among authors: mockel m. Circ Cardiovasc Interv. 2014 Aug;7(4):543-51. doi: 10.1161/CIRCINTERVENTIONS.114.001360. Epub 2014 Jun 17. Circ Cardiovasc Interv. 2014. PMID: 24939928 Clinical Trial.
261 results